510(k) device
TRANBERG Thermoguide Therapy System
Clinical Laserthermia Systems, AB · Neurosurgical Laser With Mr Thermography (ONO, Class II) · First FDA decision Sep 22, 2022, newest Sep 22, 2022Brain tumorsEpilepsy
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
1
Naming "TRANBERG Thermoguide Therapy"
MAUDE reports
0
Brand "TRANBERG Thermoguide Therapy", since 2015
PubMed studies
0
Mentioning "TRANBERG Thermoguide Therapy"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing TRANBERG Thermoguide Therapy System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K214125 · Decided Sep 22, 2022 · 266 days after receipt
Device type: Neurosurgical Laser With Mr Thermography (ONO) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "TRANBERG Thermoguide Therapy", any status and sponsor, newest update first.
Clinical Laserthermia Systems ABNot on our public-company list
NCT05296122 · 14 participants · Start May 12, 2022 · Primary completion Aug 30, 2024
Device: TRANBERG® laser applicators when used in MR-guided laser thermal ablation of brain lesions using the TRANBERG® Thermal Therapy System and TRANBERG® Thermoguide Workstation. · For: Glioblastoma
Sites: Lund, Sweden
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "TRANBERG Thermoguide Therapy", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code ONO
5 reports: 1 malfunction, 4 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "TRANBERG Thermoguide Therapy"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code ONO.
- NeuroBlate SystemMonteris Medical · 510(k) 2026
- Visualase Cooled Laser Applicator System (9735559)Medtronic Navigation, Inc. · 510(k) 2026
- Mobile Laser Unit (1001-N2)Clinical Laserthermia Systems, AB · 510(k) 2025
- Visualase V2 MRI-guided Laser Ablation System (9736422)Medtronic Navigation · 510(k) 2025
- Monteris Medical NeuroBlate SystemMonteris Medical · 510(k) 2024
- Visualase MRI-Guided Laser Ablation System (SW 3.4)Medtronic Navigation, Inc. · 510(k) 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.